Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5 ) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM). 1 * 100 mg
Catalog # MDEXHY-10453
Supplier: MEDCHEMEXPRESS
Frequently Bought Together